Literature DB >> 8719622

Impaired myelinated fiber regeneration following freeze-injury in rats with streptozotocin-induced diabetes: involvement of the polyol pathway.

A Love1, M A Cotter, N E Cameron.   

Abstract

This study examined the effects of streptozotocin-induced diabetes mellitus and aldose reductase inhibitor (ZD5522) treatment on myelinated fiber regeneration in rats. After 2 months of diabetes, with or without ZD5522 treatment (10 mg.kg-1.day-1) from induction, sciatic nerve degeneration was initiated by a punctate lesion using a liquid N2 cooled probe. Regeneration was studied over a subsequent 14-day period using in vitro electrophysiological techniques. There was a 21.4% (P < 0.001) deficit in the maximum fiber regeneration distance in diabetic rats, 14 days postlesion. This was partially (64.9%, P < 0.01) prevented by aldose reductase inhibitor treatment, the resultant regeneration distance being not significantly different from that of age-matched nondiabetic control rats. The regeneration rate, assessed from data collected 4, 9 and 14 days postlesion, was 23.7% (P < 0.001) reduced by diabetes and ZD5522 treatment provided 73.1% protection (P < 0.01). We conclude that polyol pathway activity is involved in impaired regeneration in experimental diabetes, potential pathophysiological mechanisms involving a reduction in neurotrophic support and impaired endoneurial blood supply.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719622     DOI: 10.1016/0006-8993(95)01070-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Regeneration of diabetic axons is enhanced by selective knockdown of the PTEN gene.

Authors:  Bhagat Singh; Vandana Singh; Anand Krishnan; Kurien Koshy; Jose A Martinez; Chu Cheng; Chris Almquist; Douglas W Zochodne
Journal:  Brain       Date:  2014-02-27       Impact factor: 13.501

2.  Impaired prosaposin secretion during nerve regeneration in diabetic rats and protection of nerve regeneration by a prosaposin-derived peptide.

Authors:  Corinne G Jolivalt; Yvonne Vu; Leah M Mizisin; Andrew P Mizisin; Nigel A Calcutt
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

3.  Erythropoietin both protects from and reverses experimental diabetic neuropathy.

Authors:  Roberto Bianchi; Belgin Buyukakilli; Michael Brines; Costanza Savino; Guido Cavaletti; Norberto Oggioni; Giuseppe Lauria; Monica Borgna; Raffaella Lombardi; Burak Cimen; Ulku Comelekoglu; Arzu Kanik; Cengiz Tataroglu; Anthony Cerami; Pietro Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.